Cambridge, MA, United States of America

Joseph F Nabhan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Joseph F. Nabhan: Innovator of ARRDC1-Mediated Microvesicles**

Introduction

Joseph F. Nabhan, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biomedical research through his innovative work. With a total of two patents to his name, Nabhan's latest inventions are poised to advance the way agents are delivered for therapeutic and diagnostic purposes.

Latest Patents

Joseph F. Nabhan's most recent patents focus on the development and application of ARRDC1-mediated microvesicles (ARMMs). These isolated microvesicles are generated through the activity of the arrestin domain-containing protein 1 (ARRDC1). The invention outlines methods for generating and isolating ARMMs, which can effectively deliver various agents such as nucleic acids (including siRNAs, microRNAs, and lincRNAs), proteins (such as transcription factors and kinases), and small molecules to target cells, both in vitro and in vivo. Furthermore, the patent includes diagnostic and therapeutic methodologies utilizing ARMMs, marking a significant leap in targeted treatment strategies.

Career Highlights

Joseph F. Nabhan has collaborated with renowned institutions, earning experience and knowledge that significantly contributed to his inventions. He has worked with Harvard College and the Board of Trustees of the Leland Stanford Junior University. His background reflects a strong emphasis on innovative research in a competitive academic environment, showcasing his dedication to advancing scientific understanding.

Collaborations

Throughout his career, Nabhan has had the opportunity to collaborate with esteemed colleagues, notably Quan Lu and Stanley N. Cohen. Their combined expertise has fostered a productive research environment, enhancing the potential for breakthroughs in biomedical applications.

Conclusion

Joseph F. Nabhan stands out as a forward-thinking inventor whose work with ARRDC1-mediated microvesicles demonstrates the transformative potential of innovation in healthcare. His contributions hold promise for improved therapeutic approaches, highlighting the importance of interdisciplinary collaboration in achieving scientific advancements. As the field progresses, Nabhan's inventions may pave the way for future developments in targeted delivery systems and diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…